Silver Book Fact

Cost-effectiveness of SAVR

The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).

Wu Y, Jin R, Gao G, Grunkmeier G, Starr A. Cost-Effectiveness of Aortic Valve Replacement in the Elderly: An introductory story. J Thorac Cardiovasc Surg. 2007; 133(3): 608-13. http://www.jtcvsonline.org/article/S0022-5223(06)02087-3/fulltext

Reference

Title
Cost-Effectiveness of Aortic Valve Replacement in the Elderly: An introductory story
Publication
J Thorac Cardiovasc Surg
Publication Date
2007
Authors
Wu Y, Jin R, Gao G, Grunkmeier G, Starr A
Volume & Issue
Volume 133, Issue 3
Pages
608-13
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • Disease specific status and generic health status improvements from TAVR and SAVR
    Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in intermediate risk symptomatic aortic stenosis (SAS) patients were associated with significant improvements in disease specific status (16 to…  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states
     
  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.  
  • Surgical Aortic Valve Replacements in 2010
    In 2010, ~67,500 surgical aortic valve replacements (SAVR) were performed in the U.S.